FDA Says Knome's DTC Whole-Genome Sequencing Service Requires Its Review

According to the agency, the firm's KnomeComplete offering is a diagnostic device, and consumers may make medical decisions based on the results.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.